Pages that link to "Q34362143"
Jump to navigation
Jump to search
The following pages link to The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family (Q34362143):
Displaying 50 items.
- The evolution of vertebrate opioid receptors (Q24627645) (← links)
- Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active (Q24629014) (← links)
- Buprenorphine: a unique drug with complex pharmacology (Q24642980) (← links)
- Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP (Q24647921) (← links)
- Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice (Q24672947) (← links)
- Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists (Q26852027) (← links)
- Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs (Q28088311) (← links)
- Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice (Q28266976) (← links)
- The Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse Medications (Q28297686) (← links)
- Activation of opioid receptor like-1 receptor in the spinal cord produces sex-specific antinociception in the rat: estrogen attenuates antinociception in the female, whereas testosterone is required for the expression of antinociception in the male (Q28576218) (← links)
- Nociceptin produces antinociception after spinal administration in amphibians (Q28754925) (← links)
- Synaptic effects induced by alcohol (Q30388351) (← links)
- Endogenous Opioids: The Downside of Opposing Stress (Q30394985) (← links)
- Endogenous opioids: opposing stress with a cost (Q30408911) (← links)
- The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation (Q30448074) (← links)
- Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees (Q33247174) (← links)
- Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro (Q33554431) (← links)
- Role of opioid receptor like-1 receptor in modulation of endocrine, immunological, and behavioral responses to the T-cell superantigen staphylococcal enterotoxin A (Q33625290) (← links)
- Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II. (Q33662208) (← links)
- Effects of nociceptin/orphanin FQ on rats with cathartic colon (Q33787537) (← links)
- Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons (Q33862053) (← links)
- Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma (Q33867865) (← links)
- Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111. (Q34300762) (← links)
- Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior. (Q34337014) (← links)
- Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species (Q34434739) (← links)
- A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies (Q34502250) (← links)
- The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction (Q34510753) (← links)
- Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system (Q34561447) (← links)
- The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity (Q34623161) (← links)
- The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine (Q34725890) (← links)
- Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography (Q34842096) (← links)
- Inflammatory mediators influence the expression of nociceptin and its receptor in human whole blood cultures (Q34997223) (← links)
- Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices (Q35044107) (← links)
- [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. (Q35044357) (← links)
- Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro (Q35044530) (← links)
- Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex (Q35044849) (← links)
- Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux (Q35048718) (← links)
- Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy (Q35552420) (← links)
- NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases. (Q35708377) (← links)
- Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation (Q35720961) (← links)
- Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test (Q35768240) (← links)
- Post-triptan era for the treatment of acute migraine (Q35884327) (← links)
- Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization. (Q35968136) (← links)
- In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor (Q35989343) (← links)
- Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor. (Q35999761) (← links)
- UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. (Q36188712) (← links)
- Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling (Q36451963) (← links)
- Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats (Q36499488) (← links)
- The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability (Q36638633) (← links)
- Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys (Q36733530) (← links)